Bosentan Bosentan Bosentan Bosentan Bosentan Bosentan
Bosentan
Bosentan Bosentan Bosentan Bosentan Bosentan

Bosentan

175000 INR/Kilograms

Product Details:

  • Particle Size 10 MICRON
  • Molecular Formula C27H29N5O6S
  • Loss on Drying 0.5 %
  • Heavy Metal (%) 0.5 %
  • Molecular Weight 551.614 g/mol Grams (g)
  • Taste Odorless
  • Smell No Smell
  • Supply Ability : 100 Kilograms Per Week
  • Click to view more
X

Price And Quantity

  • 175000 INR/Kilograms
  • 1 Kilograms

Product Specifications

  • 10 MICRON
  • C27H29N5O6S
  • 0.5 %
  • 99.8 %
  • Bosentan
  • Powder
  • 147536-97-8
  • White crystalline powder
  • 0.5 %
  • Bosentan Monohydrate
  • Cardiovascular Agents
  • Bosentan is a dual endothelin receptor antagonist used in the treatment of pulmonary artery hypertension
  • 551.614 g/mol Grams (g)
  • Odorless
  • 36 Months
  • Room Temperature
  • Medicine Grade
  • No Smell

Trade Information

  • SAHAR AIR CARGO
  • Cash Against Delivery (CAD), Cash on Delivery (COD), Cash Advance (CA), Delivery Point (DP), Letter of Credit (L/C), Letter of Credit at Sight (Sight L/C), Telegraphic Transfer (T/T), Western Union, Paypal, Cash in Advance (CID), Cheque, Days after Acceptance (DA)
  • 100 Kilograms Per Week
  • 2 Days
  • Yes
  • Free samples are available
  • Double LDPE Liners in HDPE carboys
  • South America, Western Europe, Asia, Australia, North America, Eastern Europe, Middle East, Africa, Central America
  • Chandigarh, Himachal Pradesh, Nagaland, Daman and Diu, Dadra and Nagar Haveli, Lakshadweep, Delhi, Arunachal Pradesh, Karnataka, Tripura, Telangana, Andhra Pradesh, Goa, Meghalaya, Kerala, Tamil Nadu, Bihar, West Bengal, Andaman and Nicobar Islands, Maharashtra, Mizoram, East India, Sikkim, Gujarat, Jharkhand, South India, Rajasthan, Pondicherry, Assam, Punjab, Jammu and Kashmir, North India, Manipur, Uttar Pradesh, Haryana, Madhya Pradesh, All India, Central India, Odisha, West India, Uttarakhand, Chhattisgarh
  • FDCA, GMP, GLP AND ISO

Product Description

The endothelin receptor antagonist bosentan belongs to this class. It increases blood flow in patients with PAH. It is typically taken once in the morning and once in the evening. To take medication, swallow it with or without water. Dissolve the tablet in a small amount of water and drink the liquid immediately after it dissolves. Store it away from heat, and direct sunlight. Do not store it in humid areas such as the bathroom. 

147536-97-8 

FORMULA: C272956 

Store in cool and dry place,keep away from direct heat and light. Do not put in humid place like bathroom. Keep away from children and pet. 

HOW TO USE: Take this medicine 2 times per day, normally in morning and evening.Take medicines by mouth with or without water. Put you tablet in small amount of water and dissolve it, when it dissolves drink whole mixture at once. 

PHARMACOKINETICS:Bosentan have very low solubility so Bosentan absorbed when it taken in high amount. The drug binds with almost 98% of plasma protein. Bioavailability of this medicine is 505 and it is not affected by food. Half-life of Bosentan in health person is 5 hrs. The Bosentan excited by the biliary excretion. 

SIDE EFFECTS OF BOSENTAN: Runny nose, dizziness, flushing and joint pain are the common side effects seen in the patients. If you see symptoms like swelling of ankles,fainting, weight gain, shortness of breath, fast heartbeat, weakness tell your doctor about this problems. This drug can effects on sperm production and also affect your ability to become father. The allergic reaction of Bosentan is rare. 

PRECAUTION: Tell your doctor if you have allergic reaction towards the Bosentan.

Talk with your doctor if you have other disease like liver or kidney problems. This rug cause dizziness so kindly avoid driving and heavy exercise. Consumption of alcohol or cannabis can make you dizzier so kindly avoid it while taking the medicament. If you must not be taken in pregnancy because it can harms the unborn baby. 

CDSCO APPROVAL: Bosentan (as monohydrate)Tablets 62.5mg/125mg approved by CDSCO in Indian in 23.06.2009. 

FORMULATIONS AVAILABLE IN MARKET: Bosentan 62.5mg tablets

Bosentan 125mg tablets 


Note: Product protected by valid patents are not offered for sale in countries where such patents are stil lvalid and its liability is at Buyers Risk 


REFERENCES: 

www.webmd.com

https://pubchem.ncbi.nlm.nih.gov

https://go.drugbank.com

https://cdscoonline.gov.in

https://www.wikipedia.org/

https://www.drugs.com

https://www.zaubacorp.com

https://www.practo.com/consult

 

Enter Buying Requirement Details
Email Id
Mobile number

Other Products in 'Active Pharmaceuticals Ingredients (API)' category



NIKSAN PHARMACEUTICAL All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.